Increasing access to erectile dysfunction treatment via pharmacies to improve healthcare provider visits and quality of life: Results from a prospective real‐world observational study in the United Kingdom-Reference-Cited by-同舟云学术

Increasing access to erectile dysfunction treatment via pharmacies to improve healthcare provider visits and quality of life: Results from a prospective real‐world observational study in the United Kingdom

Published:2020-12-05 Issue:4 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Lee Lauren J.¹,Maguire Terence A.²,Maculaitis Martine C.³^ORCID,Emir Birol⁴,Li Vicky W.³,Jeffress Mara⁵,Li Jim Z.⁶^ORCID,Zou Kelly H.⁷^ORCID,Donde Shaantanu S.⁸,Taylor David⁹

Affiliation:

1. Patient and Health Impact Pfizer Inc New York NY USA

2. School of Pharmacy Queen’s University Belfast Belfast Northern Ireland

3. Health Division Kantar New York NY USA

4. Statistical Research and Data Center Global Product Development Pfizer Inc New York NY USA

5. Health Division Kantar Los Angeles CA USA

6. Viatris San Diego CA USA

7. Viatris New York NY USA

8. Viatris Surrey United Kingdom

9. School of Pharmacy University College London London United Kingdom

Funder

Pfizer